![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Advaxis Receives FDA Response to Orphan Drug Filing
Advaxis Receives FDA Response to Orphan Drug Filing
June 3, 2009
Advaxis, Inc. received the FDA letter late on June 1 denying the company’s request for Orphan Drug Designation for the use of ADXS11-001 in invasive cervix cancer.
Earth Times
Earth Times
Upcoming Events
-
21Oct